Minimizing cost associated with management of heparin-induced thrombocytopenia: A cost analysis of various laboratory testing models.

Institutions should evaluate current HIT laboratory testing practices and assess for opportunities for optimization. Testing models utilizing a PF4-heparin antibody ELISA with a reflex SRA for positive results may improve testing metrics and lead to lower utilization of alternative anticoagulants.